1222 related articles for article (PubMed ID: 2999233)
1. Requirement of Ia-positive accessory cells in the MLR response against class II antigen on human B cell tumor line.
Yamamoto M; Yano A
J Immunol; 1985 Dec; 135(6):3887-96. PubMed ID: 2999233
[TBL] [Abstract][Full Text] [Related]
2. Two distinct class II molecules encoded by the genes within HLA-DR subregion of HLA-Dw2 and Dw12 can act as stimulating and restriction molecules.
Sone T; Tsukamoto K; Hirayama K; Nishimura Y; Takenouchi T; Aizawa M; Sasazuki T
J Immunol; 1985 Aug; 135(2):1288-98. PubMed ID: 3159789
[TBL] [Abstract][Full Text] [Related]
3. Autologous B lymphoblastoid cell lines and long-term cultured T cells as stimulators in the mixed lymphocyte reaction: analysis of the role of HLA class II antigens as stimulatory molecules.
Santoli D; Radka SF; Igarashi M; Kreider BL; Ferrone S
J Immunol; 1986 Jul; 137(2):400-7. PubMed ID: 2941479
[TBL] [Abstract][Full Text] [Related]
4. Mouse T lymphocytes proliferative responses specific for human MHC products in mouse anti-human xenogeneic MLR.
Yoshizawa K; Yano A
J Immunol; 1984 Jun; 132(6):2820-9. PubMed ID: 6202762
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibodies to HLA-DP, DQ, and DR determinants: functional effects on the activation and proliferation of normal and EBV-transformed B cells.
Howard DR; Eaves AC; Takei F
Exp Hematol; 1986 Oct; 14(9):887-95. PubMed ID: 2428652
[TBL] [Abstract][Full Text] [Related]
6. Antigen presentation by interferon-gamma-treated endothelial cells and fibroblasts: differential ability to function as antigen-presenting cells despite comparable Ia expression.
Geppert TD; Lipsky PE
J Immunol; 1985 Dec; 135(6):3750-62. PubMed ID: 3934267
[TBL] [Abstract][Full Text] [Related]
7. Ia antigen on peripheral blood mononuclear leukocytes in man. I. Expression, biosynthesis, and function of HLA-DR antigen non-T cells.
Engleman EG; Charron DJ; Benike CJ; Stewart GJ
J Exp Med; 1980 Aug; 152(2 Pt 2):99s-113s. PubMed ID: 6967944
[TBL] [Abstract][Full Text] [Related]
8. In vitro T cell responses to a candidate Epstein-Barr virus vaccine: human CD4+ T cell clones specific for the major envelope glycoprotein gp340.
Ulaeto D; Wallace L; Morgan A; Morein B; Rickinson AB
Eur J Immunol; 1988 Nov; 18(11):1689-97. PubMed ID: 2904885
[TBL] [Abstract][Full Text] [Related]
9. Human alveolar macrophages: HLA-DR-positive macrophages that are poor stimulators of a primary mixed leukocyte reaction.
Lipscomb MF; Lyons CR; Nunez G; Ball EJ; Stastny P; Vial W; Lem V; Weissler J; Miller LM
J Immunol; 1986 Jan; 136(2):497-504. PubMed ID: 2934472
[TBL] [Abstract][Full Text] [Related]
10. Human T-cell hybrids with HLA-restricted proliferative response to Epstein-Barr virus-infected B cells.
Gallagher G; Stimson WH
Immunology; 1984 Dec; 53(4):611-21. PubMed ID: 6209205
[TBL] [Abstract][Full Text] [Related]
11. Sodium periodate-induced T cell mitogenesis: an analysis of the requirement for Ia and IL 1.
Smith LA; Cohen DA; Lachman LB; Kaplan AM
J Immunol; 1985 Aug; 135(2):1137-44. PubMed ID: 2989361
[TBL] [Abstract][Full Text] [Related]
12. Accessory function of human leukemic cell lines: properties of B and B-K562 hybrid cell lines.
Wakasugi H; Dokhelar MC; Garson D; Harel-Bellan A; Fradelizi D; Tursz T
Eur J Immunol; 1985 Mar; 15(3):256-61. PubMed ID: 3872216
[TBL] [Abstract][Full Text] [Related]
13. An influenza A virus-specific and HLA-DRw8-restricted T cell clone cross-reacting with a transcomplementation product of the HLA-DR2 and DR4 haplotypes.
Gomard E; Hénin Y; Sterkers G; Masset M; Fauchet R; Lévy JP
J Immunol; 1986 Jun; 136(11):3961-7. PubMed ID: 2422266
[TBL] [Abstract][Full Text] [Related]
14. Xenogeneic recognition of soluble and cell surface HLA class II antigens by proliferative murine T cells.
Viguier M; Lotteau V; Charron D; Debré P
Eur J Immunol; 1987 Nov; 17(11):1540-6. PubMed ID: 2960540
[TBL] [Abstract][Full Text] [Related]
15. Studies on the capacity of intact cells and purified Ia from different B cell sources to function in antigen presentation to T cells.
Krieger J; Jenis DM; Chesnut RW; Grey HM
J Immunol; 1988 Jan; 140(2):388-94. PubMed ID: 2961812
[TBL] [Abstract][Full Text] [Related]
16. Ia-specific mixed leukocyte reactive T cell hybridomas: analysis of their specificity by using purified class II MHC molecules in synthetic membrane system.
Coeshott CM; Chesnut RW; Kubo RT; Grammer SF; Jenis DM; Grey HM
J Immunol; 1986 Apr; 136(8):2832-8. PubMed ID: 2420871
[TBL] [Abstract][Full Text] [Related]
17. Ia antigen on peripheral blood mononuclear leukocytes in man. II. Functional studies of HLA-DR-positive T cells activated in mixed lymphocyte reactions.
Engleman EG; Benike CJ; Charron DJ
J Exp Med; 1980 Aug; 152(2 Pt 2):114s-126s. PubMed ID: 6447741
[TBL] [Abstract][Full Text] [Related]
18. Generation of natural killer-like activity in mixed lymphocyte-tumor cell cultures. II. Correlation between expression of HLA-DR antigens on the activated T cells and their cytotoxic capability.
Santoli D; Francis MK; Matera L
Nat Immun Cell Growth Regul; 1985; 4(2):103-12. PubMed ID: 3160933
[TBL] [Abstract][Full Text] [Related]
19. Functional and molecular analysis of three distinct HLA-DR4 beta-chains responsible for the MLR between HLA-Dw4, Dw15, and DKT2.
Hirayama K; Nishimura Y; Tsukamoto K; Sasazuki T
J Immunol; 1986 Aug; 137(3):924-33. PubMed ID: 2424990
[TBL] [Abstract][Full Text] [Related]
20. Search for class II major histocompatibility complex molecular involvement in the response of Lyt-2+ cytotoxic T lymphocyte precursors to alloantigen.
Romani L; Mage MG
Eur J Immunol; 1985 Nov; 15(11):1125-30. PubMed ID: 2933265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
